טוען...
CYFRA 21-1 as a prognostic and predictive marker in advanced non-small cell lung cancer in a prospective trial: CALGB 150304
BACKGROUND: Cytokeratin 19, and its soluble fragment CYFRA, have been studied as markers that may be associated with response to therapy and survival in NSCLC. As a prospective correlative study of CALGB 30203, a randomized phase II trial of carboplatin/gemcitabine with eicosanoid modulators (celeco...
שמור ב:
| הוצא לאור ב: | J Thorac Oncol |
|---|---|
| Main Authors: | , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2012
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5541770/ https://ncbi.nlm.nih.gov/pubmed/22425913 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/JTO.0b013e31824a8db0 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|